Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lexeo Therapeutics, Inc. | 25,000 | reported | 26 Jun 2025 | tx 3+79,000 |
| Enliven Therapeutics, Inc. | 15,457 | reported | 16 Mar 2020 | tx 6+1,448,179−7,843,685 |
| Trevi Therapeutics, Inc. | 0 | reported | 09 May 2019 | tx 4+1,175,228−6,849,315 |
| scPharmaceuticals Inc. | 0 | reported | 07 Oct 2025 | tx 13+3,269,408−18,210,078 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Oct 2025 | OTHER | scPharmaceuticals Inc. | 19,750 | 0.00 USD | deriv |
| 07 Oct 2025 | OTHER | scPharmaceuticals Inc. | 30,000 | 0.00 USD | deriv |
| 26 Jun 2025 | GRANT_AWARD | Lexeo Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 03 Jun 2025 | GRANT_AWARD | scPharmaceuticals Inc. | 30,000 | 0.00 USD | deriv |
| 25 Jun 2024 | GRANT_AWARD | Lexeo Therapeutics, Inc. | 18,000 | 0.00 USD | deriv |
| 11 Jun 2024 | GRANT_AWARD | scPharmaceuticals Inc. | 19,750 | 0.00 USD | deriv |
| 02 Feb 2024 | GRANT_AWARD | Lexeo Therapeutics, Inc. | 36,000 | 0.00 USD | deriv |
| 06 Jun 2023 | GRANT_AWARD | scPharmaceuticals Inc. | 17,300 | 0.00 USD | deriv |
| 09 Jun 2020 | GRANT_AWARD | scPharmaceuticals Inc. | 6,124 | 0.00 USD | deriv |
| 16 Mar 2020 | CONVERSION | Enliven Therapeutics, Inc. | 1,245,222 | — | |
| 16 Mar 2020 | PURCHASE | Enliven Therapeutics, Inc. | 187,500 | 16.00 USD | |
| 16 Mar 2020 | CONVERSION | Enliven Therapeutics, Inc. | 5,470,492 | 0.00 USD | deriv |
| 16 Mar 2020 | CONVERSION | Enliven Therapeutics, Inc. | 1,894,444 | 0.00 USD | deriv |
| 16 Mar 2020 | GRANT_AWARD | Enliven Therapeutics, Inc. | 15,457 | 0.00 USD | deriv |
| 16 Mar 2020 | CONVERSION | Enliven Therapeutics, Inc. | 478,749 | 0.00 USD | deriv |
| 18 Jun 2019 | GRANT_AWARD | scPharmaceuticals Inc. | 6,124 | 0.00 USD | deriv |
| 09 May 2019 | PURCHASE | Trevi Therapeutics, Inc. | 375,000 | 10.00 USD | first after silence |
| 09 May 2019 | CONVERSION | Trevi Therapeutics, Inc. | 776,544 | — | |
| 09 May 2019 | CONVERSION | Trevi Therapeutics, Inc. | 6,849,315 | 0.00 USD | deriv |
| 07 May 2019 | GRANT_AWARD | Trevi Therapeutics, Inc. | 23,684 | 0.00 USD | deriv |
| 19 Jun 2018 | GRANT_AWARD | scPharmaceuticals Inc. | 6,124 | 0.00 USD | deriv |
| 21 Nov 2017 | CONVERSION | scPharmaceuticals Inc. | 984,366 | — | |
| 21 Nov 2017 | CONVERSION | scPharmaceuticals Inc. | 1,544,858 | — | |
| 21 Nov 2017 | CONVERSION | scPharmaceuticals Inc. | 11,092,383 | 0.00 USD | deriv |
| 21 Nov 2017 | CONVERSION | scPharmaceuticals Inc. | 7,067,945 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 09 May 2019.